{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"BioRestorative Therapies, Inc."},"Symbol":{"label":"Symbol","value":"BRTX"},"Address":{"label":"Address","value":"40 MARCUS DRIVE SUITE ONE, MELVILLE, New York, 11747, United States"},"Phone":{"label":"Phone","value":"+1 631 760-8100"},"Industry":{"label":"Industry","value":"Managed Health Care"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue."},"CompanyUrl":{"label":"Company Url","value":"https://www.biorestorative.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Francisco J. Silva","title":"Secretary, Director & VP-Research & Development"},{"name":"Lance Alstodt","title":"Chairman, President & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}